SE7709482L - Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat - Google Patents

Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat

Info

Publication number
SE7709482L
SE7709482L SE7709482A SE7709482A SE7709482L SE 7709482 L SE7709482 L SE 7709482L SE 7709482 A SE7709482 A SE 7709482A SE 7709482 A SE7709482 A SE 7709482A SE 7709482 L SE7709482 L SE 7709482L
Authority
SE
Sweden
Prior art keywords
formula
amino
reacting
amidoxime
amidoximi
Prior art date
Application number
SE7709482A
Other languages
English (en)
Other versions
SE435280B (sv
Inventor
K Takacs
P Literati
I Kiss
A Simay
M Szentivanyi
S Virag
K Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE7709482L publication Critical patent/SE7709482L/sv
Publication of SE435280B publication Critical patent/SE435280B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7709482A 1976-08-27 1977-08-23 Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat SE435280B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (2)

Publication Number Publication Date
SE7709482L true SE7709482L (sv) 1978-02-28
SE435280B SE435280B (sv) 1984-09-17

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709482A SE435280B (sv) 1976-08-27 1977-08-23 Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat

Country Status (23)

Country Link
JP (1) JPS5350131A (sv)
AT (1) AT355554B (sv)
AU (1) AU521432B2 (sv)
BE (1) BE858134A (sv)
CA (1) CA1077506A (sv)
CH (1) CH630344A5 (sv)
CS (1) CS204008B2 (sv)
DD (1) DD132433A5 (sv)
DE (1) DE2738589A1 (sv)
DK (1) DK150196C (sv)
ES (1) ES462346A1 (sv)
FI (1) FI68396C (sv)
FR (1) FR2362845A1 (sv)
GB (1) GB1582029A (sv)
GR (1) GR63623B (sv)
HU (1) HU177578B (sv)
IL (1) IL52804A (sv)
NL (1) NL187478C (sv)
NO (1) NO144793C (sv)
PL (1) PL107628B1 (sv)
SE (1) SE435280B (sv)
SU (1) SU730296A3 (sv)
YU (2) YU202377A (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
AU766831B2 (en) 1998-05-11 2003-10-23 Takeda Pharmaceutical Company Limited Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
AU2003202104B8 (en) 2002-01-11 2008-10-02 Cytrx Corporation Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
US20230416224A1 (en) 2020-11-19 2023-12-28 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Also Published As

Publication number Publication date
FI68396B (fi) 1985-05-31
AU521432B2 (en) 1982-04-01
ATA605477A (de) 1979-08-15
NO772958L (no) 1978-02-28
NO144793B (no) 1981-08-03
CH630344A5 (en) 1982-06-15
SU730296A3 (ru) 1980-04-25
IL52804A (en) 1981-06-29
DK150196C (da) 1987-07-06
HU177578B (en) 1981-11-28
CS204008B2 (en) 1981-03-31
FI772551A (fi) 1978-02-28
NO144793C (no) 1981-11-11
JPS6216942B2 (sv) 1987-04-15
IL52804A0 (en) 1977-10-31
FR2362845A1 (fr) 1978-03-24
PL107628B1 (pl) 1980-02-29
NL7709276A (nl) 1978-03-01
DK379777A (da) 1978-02-28
AU2825477A (en) 1979-03-01
DE2738589A1 (de) 1978-03-02
JPS5350131A (en) 1978-05-08
ES462346A1 (es) 1978-06-16
YU202377A (en) 1983-12-31
YU237782A (en) 1983-12-31
DK150196B (da) 1987-01-05
SE435280B (sv) 1984-09-17
GR63623B (en) 1979-11-27
NL187478C (nl) 1991-10-16
DD132433A5 (de) 1978-09-27
GB1582029A (en) 1980-12-31
FI68396C (fi) 1985-09-10
BE858134A (fr) 1977-12-16
FR2362845B1 (sv) 1981-01-09
AT355554B (de) 1980-03-10
CA1077506A (en) 1980-05-13

Similar Documents

Publication Publication Date Title
SE7709482L (sv) Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat
MX152556A (es) Procedimiento para preparar eteres a base de polialquil-1-oxadiazespirodecano
DK156719C (da) Analogifremgangsmaade til fremstilling af 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphanforbindelser eller syreadditionssalte deraf
DK153581A (da) 3-(1,4-benzodioxan-2-yl-methoxy)-2-propanolaminer samt fremgangsmaade til fremstilling deraf
SE7702668L (sv) Nya stilbenforeningar och forfarande for deras framstellning
GB1013893A (en) The production of pyridoxol and analogues thereof
FI792206A (fi) Foerfarande foer framstaellning av nya oxadiazolopyrimidinderivat
ES403486A1 (es) Procedimiento para la preparacion de derivados de piperazi-na.
DK160310C (da) Analogifremgangsmaade til fremstilling af 6-oe(cyclisk amino)ethylaminoaatetrahydrotriazolooe3,4-aaaphthalaziner eller farmaceutisk acceptable syreadditionssalte deraf
GB1410581A (en) Light-sensitive photographic materials
GB1394356A (en) Process for preparing tris 2-haloalkyl phosphites
SE7710059L (sv) Forfarande for framstellning av amidderivat vinblastin, av leurosidin, leurokristin och beslektade dimera alkaloider
SE9702306D0 (sv) Diclavulanate salt with a diamino ether and process of preparation
ES421182A1 (es) Procedimiento para preparar 1-fenoxi-3-fenoxi-etilamino-2- propanoles.
ATE117680T1 (de) Verfahren zur herstellung von gegebenenfalls substituierten ethansulfobetainverbindungen.
SE7609391L (sv) Sett att framstella 1-bensoyl-2-(2',6'-diklorfenylamino)-2-imidazolin och salter derav
ES397057A1 (es) Procedimiento para la preparacion de nuevos epoxi-isociana-tos.
KR830006199A (ko) 3,6-비스(카르보에톡시아미노)-2,5-디아지리디닐-1,4-벤조퀴논의제조방법
ES8105363A1 (es) Procedimiento para la obtencion de colorantes cationicos de hidrazona
DE2960787D1 (en) Process for preparing alpha, beta-dihalogeno-alkyl isocyanates
FR2322141A1 (fr) Procede de production d'oxazolidines n-substituees
GB1536685A (en) Process for the preparation of 1,1-dihalo-1,3-dienes
GB833008A (en) Improvements in and relating to diquaternary compounds
ES429698A2 (es) Procedimiento para la preparacion de bencilaminas.
ES8300079A1 (es) Un procedimiento para la preparacion de polieteres mocrociclicos del tipo ejemplificado por 1,4,7,10,13,16-hexaoxaciclooctadecano.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7709482-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7709482-9

Format of ref document f/p: F